ulixertinib

16ZDH50O1U

1H-Pyrrole-2-carboxamide, 4-[5-chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-

4-[5-Chlor-2-(isopropylamino)-4-pyridinyl]-N-[(1S)-1-(3-chlorphenyl)-2-hydroxyethyl]-1H-pyrrol-2-carboxamid

4-[5-Chloro-2-(isopropylamino)-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide

4-[5-Chloro-2-(isopropylamino)-4-pyridinyl]-N-[(1S)-1-(3-chlorophényl)-2-hydroxyéthyl]-1H-pyrrole-2-carboxamide

4-{5-CHLORO-2-[(PROPAN-2-YL)AMINO]PYRIDIN-4-YL}-N-[(1S)-1-(3-CHLOROPHENYL)-2-HYDROXYETHYL]-1H-PYRROLE-2-CARBOXAMIDE

869886-67-9

ulixertinib

ulixertinib

ulixertinib

ulixertinibum

уликсертиниб

أوليكسيرتينيب

优立替尼

(S)-4-(5-chloro-2-(isopropylamino)pyridin-4-yl)-N-(1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide

4-(5-chloro-2-(isopropylamino)pyridin-4-yl)-N-((S)-1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide

4-[5-chloro-2-(isopropylamino)-4-pyridyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxy-ethyl]-1H-pyrrole-2-carboxamide

4-[5-chloro-2-(isopropylamino)-4-pyridyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide

4-[5-CHLORO-2-(ISOPROPYLAMINO)PYRIDIN-4-YL]-N-[(1S)-1-(3-CHLOROPHENYL)-2-HYDROXYETHYL]-1H-PYRROLE-2-CARBOXAMIDE

869886-67-9 (free base)

BVD-523(Ulixertinib)

MFCD22543853

MFCD22628898

Mitogen-activated protein kinase 1

Mitogen-activated protein kinase 3

MK01_HUMAN

MK03_HUMAN

N-[(1S)-1-(3-chlorophenyl)-2-hydroxy-ethyl]-4-[5-chloro-2-(propan-2-ylamino)pyridin-4-yl]-1H-pyrrole-2-carboxamide

N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-4-[5-chloro-2-(propan-2-ylamino)pyridin-4-yl]-1H-pyrrole-2-carboxamide

Ulixertinib (BVD-523)

Ulixertinib (BVD-523, VRT752271)

Ulixertinib (BVD-523,VRT752271)

Ulixertinib;VRT 752271;VRT-752271

ulixertinibum

vrt-752271.hcl

vrt752271(hcl)

уликсертиниб

أوليكسيرتينيب

优立替尼